This Guide is Now Mobile Compliant
Originally Posted on 01/21/2019 @ 2:34 pm EST
by Steven Warrenfeltz
Subscribe to this Blog
This guide is a little unusual to other guides because it is not only for those interested in physical precious metals bullion, it also advocates for and donates to Gold Nanoparticle Cancer Research through the Angel of Healing Cancer Research Fund.
Gold nanoparticles are a better way to treat cancer than today's methods.
Gold Nanoparticles are non-toxic, bio-compatible, and they can be made to ONLY attack and kill cancer cells, meaning there are no life-threatening side-effects associated with this research.
Below is a glimpse into what you'll find in this report :
The last blog post that was published by this guide on Gold Nanoparticle Cancer Research was a Q and A with Dr. Naomi J. Halas of Rice University in Houston, Texas.
The 3rd question that was asked was:
"What is your perspective on how close or far away Gold NanoParticle Cancer Therapy is from coming into the market?"
In Dr. Halas's answer, she stated that human clinical trials are (Nov. 2018) being done on men with prostate cancer with nanoparticles from Nanospectra Biosciences (a company she co-founded).
In addition, she stated that Dr. Rastinehad of Mt. Sinai Hospital, and Steven E. Canfield, MD of UT Health are currently conducting human trials using her Gold Nanoshells.
Frank Billingsley, is one of the individuals who was participating in the Houston clinical trial, he also happens to be a weatherman for a local Houston, TV station.
His progress is reported in the video below.
Furthermore, the following excerpt was taken from the 'Technology Networks' article about Dr. Naomi J. Halas's Gold Nanoparticle Prostate Cancer Treatment:
Doug Flewellen, the first patient in Texas to receive the new method of care, says for him, the procedure was a no-brainer.
Currently, to view molecular structures inside the body, researchers use a device called an Optical Coherence Tomography or OCT.
The imaging system is often used by ophthalmologists to study the different structures of the eye.
Researchers in this study combined the OCT with gold nano-prisms, the gold nanoprism's light refraction properties enhanced the details of the OCT, making the images sharper with more detail.
In their study, they also found the combination created a very powerful magnifying glass that could image its immediate surroundings.
The following excerpt was taken from the Stanford Medicine article about the study:
They "first demonstrated the technique by imaging blood vessels and melanoma tumors in a mouse's ear: Regular OCT showed an intricate web of vessels, all forking in different direction."
"But with the addition of gold nanoprisms, a scan of the same area was nearly opaque with vessels, revealing a huge number of blood conduits that hadn't been seen before." - Stanford Medicine
Adam de la Zerda, PhD, the assistant professor of structural biology, sees the new imaging technique as a "potential step for assessing cancer drug efficacy."
Currently, the study only involves the use of live mice as their test subjects because the gold nanoprisms have to be approved by the FDA before they can be used on humans.
However, the researchers are hoping to expand their research while they wait on the approval.
First off, to be clear, this test can't tell you what kind of cancer someone would have, just that cancer was present in their system.
So, in a scenario where someone had an unknown issue, with their body, that doctors couldn't pinpoint, this quick and low-cost method would replace the current cancer diagnosis methods to find out if cancer was or wasn't the issue.
This study revolves around the different ways that DNA acts in a healthy cell compared to mutating cancerous cell.
Scientists out of the University of Queensland in Australia found that if cancerous DNA, of any kind, is present in the test that the gold nanoparticles would change color.
The Lead professor stated the following about the study's results:
"We certainly don’t know yet whether it’s the holy grail for all cancer diagnostics, but it looks really interesting as an incredibly simple universal marker of cancer, and as an accessible and inexpensive technology that doesn’t require complicated lab-based equipment like DNA sequencing" - Matt Trau, professor of chemistry at the University of Queensland
Thank You for your Time.
Take Care & God Bless,